首页    期刊浏览 2024年09月20日 星期五
登录注册

文章基本信息

  • 标题:Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
  • 本地全文:下载
  • 作者:Javier Donate-Correa ; Carla M. Ferri ; Ernesto Martín-Núñez
  • 期刊名称:Scientific Reports
  • 电子版ISSN:2045-2322
  • 出版年度:2021
  • 卷号:11
  • DOI:10.1038/s41598-021-95488-4
  • 语种:English
  • 出版社:Springer Nature
  • 摘要:Chronic kidney disease (CKD) has been associated with a higher risk of cardiovascular disease (CVD). CKD patients present a decrease in the levels of the protein Klotho that accompanies the decrease in kidney function. This protein has been related to protective effects against CVD. However, it is unclear whether circulating Klotho, and its expression in peripheral blood cells (PBCs) are also associated with subclinical atherosclerosis in CKD. The present study aimed to study the relationship between Klotho and subclinical atherosclerosis in a population of patients with moderate to severe CKD. We determined the serum levels and gene expression in PBCs levels of Klotho and three inflammatory cytokines in 103 patients with CKD and investigated their relationship with two surrogate markers of subclinical atherosclerotis: ankle-brachial index (ABI) and carotid intima-media thickness (CIMT). Patients with subclinical atherosclerosis presented lower serum and PBCs expression levels of Klotho. Both variables were associated with the presence of subclinical atherosclerosis, being directly related with ABI and inversely with CIMT ( P  < 0.0001 for both). Multiple regression analysis demonstrated that both variables were significant determinants for ABI (adjusted R 2  = 0.511, P  < 0.0001) and CIMT (adjusted R 2  = 0.445, P  < 0.0001), independently of traditional and emergent cardiovascular risk factors. Moreover, both constituted protective factors against subclinical atherosclerosis [OR: 0.993 ( P  = 0.002) and 0.231 ( P  = 0.025), respectively
国家哲学社会科学文献中心版权所有